新华制药：关于拟续聘2026年度会计师事务所的公告

Core Viewpoint - Xinhua Pharmaceutical announced the proposal to reappoint Crowe Horwath as the auditing firm for the fiscal year 2026, with an audit service fee of 760,000 yuan (including tax) [1] Group 1 - The audit service fee is set at 760,000 yuan, which includes tax [1] - The proposal has been approved by the board of directors and is pending approval from the shareholders' meeting [1] - The signing project partner is Li Chunxu, with independent review partner Liu Zhizeng and signing CPA Kong Xiangnan [1]